Oncology is a branch of medicine that deals with the scientific study, diagnosis, prevention, and treatment of various types of cancers. An oncologist is a medical expert who specializes in the diagnosis and treatment of different kinds of cancer. Oncologists manage the treatment and care of people who have been diagnosed with cancer. There are various types of oncologists. This depends on the specific type of cancer they treat. A gynecological-oncologist treats gynecologic cancer including cervical and uterine cancer while a hematologist-oncologist treats blood cancer that includes leukemia and myeloma. All medical research articles that relate to oncology are published in the Oncortaget Journal. This is a peer-reviewed journal that is published by Impact Journal Publishers on a weekly basis. It allows open access to members of the public.Mikhail Blagosklonny is the current oncologist professor at the Roswell Park Cancer Institute.
His success history is traced back from his educational background and career experience. He acquired his Master’s degree in Internal Medicine and a Ph.D. in Experimental Medicine and Cardiology from The Pavlov State Medical University of St. Petersburg. He has been managing the institution under his current position since 2009. He previously worked as a senior scientist at the Ordway Research Institute in Albany, New York City. Mikhail was an associate professor of Medicine at the New York Medical College at Valhalla in New York in 2002. Mikhail Blagosklonny’s career specialization mainly lies in the treatment of cancer through various cancer therapies that protect the normal cells from damage and the use of Biogerontology that explores the mechanisms of aging and anti-aging drugs.Mikhail is recognized as the editor-in-chief of Oncortarget Journal. He is historically known to have published more than two hundred and seventy papers in Oncotarget. He has featured more than twenty-five thousand citations. This has increased his popularity and fame in a significant way.
Mikhail makes significant contributions in the Oncotarget’s Board of Cell Death and Differentiation. He holds the position of an Associate editor of cancer biology and therapy in the journal. Mikhail is the founder and editor-in-chief of the Cell Cycle Journal. He continues to make more publications in the Oncortarget. This has raised his h-index of 83 even higher. Mikhail Blagosklonny continues to enhance his specialization in cancer through conducting scientific research on the cure for cancer. He researched the effectiveness of Rapamycin drug in curing cancer. He concluded that the medicine could cure cancer and is also efficient in life elongation after his analysis.Blagosklonny is remarkably known for inventing a theory on the competence of TOR Signaling in curing cancer and dealing with aging. He has also written many books that relate to cell Chemotherapeutic and Cyclotherapy Engineering. His core mission is to free the world and humanity from diseases. His achievements are an outcome of his indisputable hard work and esteem for a healthy human coexistence. Mikhail Blagosklonny is one of the most famous oncological researchers, an accomplished physician, scientist, and professor of Medicine and Oncology.